1-4 of 4
reviparin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Non-Pathogenic Anti-Heparin/PF4 Antibodies Generated by Low Molecular Weight Heparins Mediate Procoagulant Effects.

Jeanine M. Walenga, PhD, Debra Hoppensteadt, PhD, Evangelos Litinas, MD, Harry L. Messmore, Jr, MD, Bruce E Lewis, MD, Gundu Rao, PhD, Russell Hull, MD, Jawed Fareed, PhD
Journal: Blood
Blood (2010) 116 (21): 1091.
https://doi.org/10.1182/blood.V116.21.1091.1091
Published: 2010
Journal Articles

Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins as Measured by Whole Blood Act, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay.

D. Hoppensteadt, PhD, M. Tobu, MD, R. Wahi, MD, O. Iqbal, MD, J. M. Walenga, PhD, M. Demir, MD, F. Baltasar, BS, J. Fareed, PhD
Journal: Blood
Blood (2005) 106 (11): 4148.
https://doi.org/10.1182/blood.V106.11.4148.4148
Published: 2005
Journal Articles

Discordance between the 1 st and 2 nd Low Molecular Weight Heparin Standards. Implications for Dosing.

Walter P. Jeske, PhD, Josephine Cunanan, MD, Debra Hoppensteadt, PhD, Jeanine M. Walenga, PhD, Omer Iqbal, MD, Michelle Florian-Kujawski, BS, Jawed Fareed, PhD
Journal: Blood
Blood (2005) 106 (11): 4158.
https://doi.org/10.1182/blood.V106.11.4158.4158
Published: 2005
Journal Articles

Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis

Clinical Trials & Observations
Vijay V. Kakkar, Debra A. Hoppenstead, Jawed Fareed, Zbigniew Kadziola, Mike Scully, Roumen Nakov, Hans K. Breddin
Journal: Blood
Blood (2002) 99 (6): 1965–1970.
https://doi.org/10.1182/blood.V99.6.1965
Published: 2002